Literature DB >> 12464861

Adjusting surgical mortality rates for patient comorbidities: more harm than good?

Emily V A Finlayson1, John D Birkmeyer, Therese A Stukel, Andrea E Siewers, F Lee Lucas, David E Wennberg.   

Abstract

Background. Studies of medical admissions have questioned the validity of using claims data to adjust for preexisting medical conditions (comorbidities), but the impact of using comorbidities from claims data to risk-adjust mortality rates for high-risk surgery is not well characterized. The purpose of this study was to evaluate the relationship between comorbidities and mortality in administrative data in surgical populations and identify better risk-adjustment methods. Methods. Using the national Medicare database (1994-1997), we identified admissions for elective abdominal aortic aneurysm repair (140,577) and pancreaticoduodenectomy (10,530). We calculated the relative risk of mortality (adjusted for age, sex, race, and admission acuity) for 5 chronic conditions that are known (from clinical series) to increase the risk of postoperative mortality and are commonly used in claims-based risk-adjustment models. To explore the potential value of alternative risk-adjustment strategies, we examined relationships between surgical mortality and comorbidities using diagnosis codes identified from previous admissions. Results. Overall, in-hospital mortality for elective abdominal aortic aneurysm (AAA) repair and pancreaticoduodenectomy were 5.1% and 10.4%, respectively. For both procedures, 3 of the 5 comorbidities were associated with decreased risk of mortality: prior myocardial infarction (MI) [RR = 0.38; 95% confidence interval (CI), 0.33-0.43 for AAA; RR = 0.38; 95% CI, 0.21-0.69 for pancreaticoduodenectomy), malignancy (RR = 0.67; 95% CI, 0.59-0.76 for AAA; RR = 0.74; 95% CI, 0.45-1.21 for pancreaticoduodenectomy], and diabetes (RR = 0.76; 95% CI, 0.64-0.84 for AAA; RR = 0.59; 95% CI, 0.49-0.69 for pancreaticoduodenectomy). Using comorbidities identified from prior admissions increased the mortality risk estimates for prior MI (RR = 1.22; 95% CI, 1.08-1.38 for AAA; RR = 0.80; 95% CI, 0.49-1.30 for pancreaticoduodenectomy) and diabetes (RR = 1.41; 95% CI, 1.25-1.59 for AAA; RR = 0.94; 95% CI, 0.78-1.14 for pancreaticoduodenectomy). Conclusions. Because comorbidities coded on the index admission appear protective, incorporating them in risk-adjustment models for studies comparing surgical performance may penalize providers for taking care of sicker patients. When available, comorbidity information from prior hospitalizations may be more useful for risk adjustment.

Entities:  

Mesh:

Year:  2002        PMID: 12464861     DOI: 10.1067/msy.2002.126509

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  16 in total

1.  Large increases in spending on postacute care in Medicare point to the potential for cost savings in these settings.

Authors:  Amitabh Chandra; Maurice A Dalton; Jonathan Holmes
Journal:  Health Aff (Millwood)       Date:  2013-05       Impact factor: 6.301

2.  Multimorbidity and access to major cancer surgery at high-volume hospitals in a regionalized era.

Authors:  Chukwuemeka Ihemelandu; Chaoyi Zheng; Erin Hall; Russell C Langan; Nawar Shara; Lynt Johnson; Waddah Al-Refaie
Journal:  Am J Surg       Date:  2016-02-28       Impact factor: 2.565

3.  Health state information derived from secondary databases is affected by multiple sources of bias.

Authors:  Darcey D Terris; David G Litaker; Siran M Koroukian
Journal:  J Clin Epidemiol       Date:  2007-04-08       Impact factor: 6.437

4.  Epidemiology of surgically treated gastric cancer in the United States, 1988-2000.

Authors:  Reid M Wainess; Justin B Dimick; Gilbert R Upchurch; John A Cowan; Michael W Mulholland
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

5.  Insurance status predicts access to care and outcomes of vascular disease.

Authors:  Jeannine K Giacovelli; Natalia Egorova; Roman Nowygrod; Annetine Gelijns; K Craig Kent; Nicholas J Morrissey
Journal:  J Vasc Surg       Date:  2008-06-30       Impact factor: 4.268

6.  A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia.

Authors:  Jonathan L Eliason; Reid M Wainess; Mary C Proctor; Justin B Dimick; John A Cowan; Gilbert R Upchurch; James C Stanley; Peter K Henke
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

7.  Overuse of preoperative cardiac stress testing in medicare patients undergoing elective noncardiac surgery.

Authors:  Kristin M Sheffield; Patricia S McAdams; Jaime Benarroch-Gampel; James S Goodwin; Casey A Boyd; Dong Zhang; Taylor S Riall
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

8.  Outcome after pancreaticoduodenectomy for periampullary cancer: an analysis from the Veterans Affairs National Surgical Quality Improvement Program.

Authors:  Kevin G Billingsley; Kwan Hur; William G Henderson; Jennifer Daley; Shukri F Khuri; Richard H Bell
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

9.  Hospital factors and racial disparities in mortality after surgery for breast and colon cancer.

Authors:  Tara M Breslin; Arden M Morris; Niya Gu; Sandra L Wong; Emily V Finlayson; Mousumi Banerjee; John D Birkmeyer
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

10.  In-hospital mortality after stomach cancer surgery in Spain and relationship with hospital volume of interventions.

Authors:  Marisa Baré; Joan Cabrol; Jordi Real; Gemma Navarro; Rafel Campo; Carles Pericay; Antonio Sarría
Journal:  BMC Public Health       Date:  2009-08-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.